BPH Photo: What an Enlarged Prostate Looks Like

An enlarged prostate caused by benign prostatic hyperplasia (BPH) looks like a swollen, rounded version of the walnut-sized gland it once was, sometimes ballooning to the size of a lemon or even a small orange. What you see depends entirely on how you look: on ultrasound, it appears as a gray, bulging mass squeezing the urinary channel into a narrow slit; on MRI, it shows up as a mixture of bright and dark nodules clustered in the gland’s interior; and through a surgical camera threaded up the urethra, the enlarged lobes look like smooth, fleshy hills pressing inward from both sides. The visual story of BPH is richer and stranger than most people expect, and the way it grows determines much of whether it causes trouble.

What a Normal Prostate Looks Like as a Baseline

To understand what enlargement changes, you need a mental picture of the starting point. A healthy adult prostate sits just below the bladder and wraps around the urethra like a donut. In younger men, it weighs roughly 11 grams and measures about the size of a walnut or a chestnut.¹ It has a smooth, slightly rubbery surface and a roughly symmetrical shape when viewed from the outside. On cross-section or imaging, the gland is divided into distinct zones. The peripheral zone makes up the bulk of the gland and sits toward the back, which is why a doctor can feel it during a rectal exam. The transition zone, a much smaller region right around the urethra, is where almost all BPH growth originates. In a young man, the transition zone is barely noticeable on imaging. That changes dramatically with age.

Where the Growth Happens

BPH is not a uniform swelling of the entire prostate. The enlargement is concentrated in the transition zone, the inner ring of tissue surrounding the urethra. Research using imaging across age groups has shown that the transition zone is the parameter most closely tied to aging, with the fastest rate of increase happening between ages 50 and 69.² This is why BPH causes urinary problems so effectively: the tissue that grows the most is the tissue right next to the tube you urinate through. On imaging, the transition zone in a man with BPH can dwarf the rest of the gland, sometimes accounting for the majority of total prostate volume. The peripheral zone, by contrast, gets compressed into a thin shell along the back of the gland. On MRI, this compressed shell is sometimes called the “surgical capsule” because it marks the boundary surgeons aim for when removing the overgrown tissue.

Understanding this geography also matters because the transition zone is where about 30 percent of prostate cancers develop, and BPH nodules in the same zone can look confusingly similar on imaging.³ That overlap between BPH and cancer on imaging is one of the reasons follow-up testing matters even when enlargement seems obviously benign.

What BPH Looks Like on Ultrasound

Transrectal ultrasound is one of the most common ways doctors visualize and measure an enlarged prostate. The probe sits in the rectum, just millimeters from the gland, and produces a real-time grayscale image. A normal prostate on ultrasound is a small, relatively homogeneous oval. A prostate with BPH looks markedly different: it is bigger, rounder, and the interior is often a patchwork of brighter and darker areas representing different types of overgrown tissue. Nodules may appear as distinct round structures within the gland.

In studies comparing men with BPH to controls, the volume difference is dramatic. One study of men with benign prostatic enlargement found a mean prostate volume of about 52 cubic centimeters, nearly three times the roughly 18 cubic centimeters measured in controls.⁴ That is the difference between a chestnut and something closer to a tangerine. On the ultrasound screen, the enlarged gland pushes against and indents the base of the bladder, and the urethra appears as a compressed or displaced bright line running through a now-massive transition zone. Doppler ultrasound can also reveal increased blood flow within the enlarged tissue, adding color to the grayscale picture and showing that the overgrown areas are well-supplied with blood vessels.

What BPH Looks Like on MRI

MRI offers the sharpest soft-tissue contrast of any imaging method and paints a detailed portrait of BPH. On T2-weighted MRI sequences (the type most useful for prostate anatomy), the different tissue types within BPH show up as a mosaic. Glandular nodules, made up of fluid-filled ducts, appear bright white. Stromal nodules, made up of fibrous and muscular tissue, appear darker. Many BPH nodules are a mix of both, so they end up somewhere in between. The overall effect is a gland that looks internally chaotic compared to the relatively uniform appearance of a young, healthy prostate.

MRI is valuable because it can distinguish BPH tissue from potential cancer more effectively than ultrasound. BPH nodules in the transition zone often have well-defined borders and characteristic signal patterns. Cancers hiding within BPH tend to show restricted water diffusion on a specific MRI sequence, but the overlap is real: the signal from predominantly stromal BPH can closely mimic cancer, making transition zone cancers easy to miss.⁵ MRI can also estimate how much of the enlargement is glandular versus stromal, determine the overall volume of each zone, and classify the specific pattern of BPH growth, all of which can guide treatment decisions.⁶

The View From Inside the Urethra

Cystoscopy gives the most visceral picture of what BPH looks like. A thin camera is passed through the penis and up the urethra, and the surgeon sees the prostate from the inside out. In a normal prostate, the urethral passage is open and the walls are relatively flat. In BPH, the view is strikingly different: the lateral lobes of the prostate bulge inward like two hills or cushions, narrowing the channel to a slit or crescent. When these lobes swell enough to touch each other, urologists call them “kissing lobes,” a term that vividly describes what the camera sees. In one study of kidney transplant recipients who needed prostate surgery, kissing lobes were detected by cystoscopy in every case of BPH, even though a physical rectal exam had judged the enlargement to be minimal in most of those same patients.⁷

That disconnect is telling. The prostate can look perfectly normal from the outside, felt through the rectal wall, while on the inside it has grown dramatically inward. This is why some men with apparently small prostates on exam still have severe urinary obstruction: the growth is directed inward toward the urethra rather than outward where a finger can detect it.

The Middle Lobe and Intravesical Protrusion

One of the most distinctive visual features of BPH is something many patients never hear about: the middle lobe, also called the median lobe. While the lateral lobes grow on either side of the urethra, the median lobe grows upward, pushing into the base of the bladder itself. On ultrasound or cystoscopy, this looks like a rounded mound or peduncle projecting up through the bladder neck, sometimes described as a ball sitting in a socket. The clinical term for this is intravesical prostatic protrusion, or IPP.

Middle lobe enlargement creates a distinctive type of obstruction that works like a ball valve. As the bladder contracts to push urine out, the protruding lobe gets wedged into the bladder outlet, blocking flow. This mechanism is different from the lateral lobe compression described above, and it tends to produce a frustrating mix of both storage symptoms (urgency, frequency, waking at night) and voiding symptoms (weak stream, straining, incomplete emptying).⁸ IPP is graded on a scale from mild to severe based on how far the tissue protrudes into the bladder, and this measurement turns out to be one of the strongest predictors of whether medication will work or whether surgery will be needed.

Middle lobe protrusion matters visually and practically because it changes what treatment options are on the table. Some minimally invasive procedures work well for lateral lobe enlargement but are less effective when a prominent median lobe is present. Failing to detect IPP on imaging can lead to refractory symptoms because the condition may not respond to the standard first-line medications.⁹

Why a Bigger Prostate Does Not Always Mean Worse Symptoms

One of the most counterintuitive things about BPH is that how big the prostate looks on imaging does not reliably predict how miserable the patient is. You might assume that a prostate twice the normal size causes twice the trouble, but the evidence consistently shows the relationship is weak. A study measuring prostate volume on ultrasound and comparing it to symptom severity scores found only a weak, statistically non-significant correlation between volume and symptom burden.¹⁰ Some men with massively enlarged glands urinate relatively well, while others with modestly enlarged prostates are up five times a night.

What seems to matter more than raw size is the pattern and direction of growth. Median lobe size, specifically, shows a much stronger link to symptom severity. In one observational study, patients with large median lobes had symptom scores nearly triple those of patients with small median lobes.¹¹ The geometry of the obstruction, the compliance of the bladder, and how the body has adapted all matter as much as the number of cubic centimeters on a scan. This is why urologists do not base treatment decisions on prostate size alone. A photo or ultrasound image of an enormous prostate does not tell you how the patient feels.

What BPH Does to the Bladder Wall

The visual effects of BPH extend beyond the prostate itself. When the prostate blocks urine outflow for months or years, the bladder has to work harder to push urine past the obstruction, and that extra effort physically changes the bladder wall. On imaging or during surgery, an obstructed bladder develops a characteristic appearance called trabeculation: the muscle bundles of the bladder wall thicken and become visible as raised ridges, giving the inside of the bladder a cobblestone or mesh-like texture instead of the smooth lining seen in a healthy bladder.

Research describes this remodeling as a progressive sequence. First, the bladder muscle thickens in response to the extra workload. Then the wall stiffens with increased connective tissue. Eventually, if the obstruction persists, the muscle loses its ability to contract effectively, and the bladder wall becomes thin and floppy, unable to empty properly.¹² In advanced cases, the bladder may develop small pouches called diverticula, where the lining herniates outward through weakened muscle. On imaging, these pouches look like balloon-like outgrowths from the bladder wall. These secondary changes are important because even if the prostate obstruction is eventually treated, a badly remodeled bladder may not fully recover its function.

What BPH Tissue Looks Like Under a Microscope

If you zoomed in on BPH tissue removed during surgery, you would see a mix of two main cell types. Glandular tissue consists of branching ducts and sacs lined with secretory cells, often dilated and filled with fluid, giving them a honeycomb-like appearance. Stromal tissue is denser, made up of smooth muscle fibers and connective tissue woven together. Most BPH nodules contain both, but the ratio varies. Some are predominantly glandular, appearing spongy and cystic, while others are predominantly stromal, looking firmer and more fibrous under the microscope.

This stromal-versus-glandular distinction is not just academic. BPH is fundamentally a proliferative process, and recent research using gene expression analysis in animal models has found that immune response pathways and complement pathways are activated during stromal growth, suggesting that autoimmune-like reactions play a role in driving the enlargement.¹³ The tissue type also influences how the gland responds to medication: alpha-blockers relax the smooth muscle component of the stroma, while 5-alpha reductase inhibitors shrink the glandular component by reducing hormone-driven growth. A heavily stromal prostate responds differently to drugs than a predominantly glandular one, which is one reason the same medication works well for some men and poorly for others.

What the Prostate Looks Like After Treatment

Treatment for BPH aims to change what the prostate looks like internally, creating more room for urine to flow. In traditional surgical procedures like transurethral resection, the surgeon uses an electrical loop to shave away the obstructing tissue from the inside, carving out a channel through the enlarged lobes. The result, visible on post-operative imaging or cystoscopy, is a wide, open cavity where the narrowed urethra used to be. Photoselective vaporization using a laser achieves a similar result, with the goal being complete removal of the obstructing overgrowth down to the level of the capsular fibers, creating a cavity similar to what you would see after conventional resection.¹⁴

Newer minimally invasive approaches produce different visual results. A procedure called UroLift uses small implants to physically pin the enlarged lobes apart, like curtain tie-backs pulling fabric away from a window. On cystoscopy afterward, you can see the implant anchors holding the tissue to the side, with an open channel between them. The prostate tissue itself is not removed, just repositioned. Rezum, another newer option, injects steam into the obstructing tissue, causing it to die and be absorbed by the body over weeks. On imaging a few months after Rezum, the treated areas appear shrunken and the prostate volume is reduced. Research comparing the two has found that Rezum, because it actually destroys tissue rather than just pushing it aside, may offer more durable results, particularly in men with prominent median lobes where the mechanical approach of UroLift is less effective at addressing the underlying enlargement.¹⁵

Why BPH Develops in Almost All Aging Men

BPH is sometimes framed as a disease, but visually and biologically it is closer to a near-universal feature of male aging. Prostatic hyperplasia develops in almost all men who retain functioning testes as they age, a pattern shared with dogs, which are the only other species that commonly develops this condition.¹⁶ The dependence on intact testes highlights the hormonal basis of the process: without ongoing testosterone production, the transition zone does not enlarge. This is why castration was historically used as a treatment for severe BPH, and why modern 5-alpha reductase inhibitors, which block the conversion of testosterone to its more potent form within the prostate, can shrink the gland by reducing the hormonal signal that drives growth.

The near-universality of BPH means that if you lined up prostate images from a group of 70-year-old men, the majority would show some degree of enlargement. The visual norm for an older man’s prostate is not the compact walnut of a 25-year-old. What varies is whether the enlargement happens to press on the urethra in a way that causes symptoms, which circles back to the geometry and growth pattern being more important than sheer size.

3D Models and Why Visual Aids Help

One practical challenge with BPH is that it is hard for patients to understand what is happening inside their body based on a verbal description alone. The prostate’s relationship to the bladder, urethra, and rectum is spatially complex, and the idea that a gland you have never seen is squeezing a tube you cannot feel is abstract. Researchers in Senegal tested whether showing patients a 3D digital model of the prostate, based on McNeal’s zonal anatomy that divides the gland into five distinct areas, improved their understanding of their condition and the planned procedure. The model included the urethra and rectum to help explain both the impaired urinary flow and why a rectal exam works for detecting prostate changes.³ The effort reflects a growing recognition that pictures, models, and visual explanations are not just nice extras in urology. For a condition where the direction and pattern of growth determines treatment choices, helping patients see what their specific enlargement looks like can make a real difference in shared decision-making about whether to try medication, pursue a procedure, or simply monitor over time.